Capstone Investment Advisors
BMY icon

Capstone Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Capstone Investment Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$46.5M Buy
767,000
+47,400
+7% +$2.76M 0.08% 97
2025
Q4 		$38.8M Sell
719,600
-10,400
-1% -$500K 0.08% 114
2025
Q3 		$32.9M Buy
730,000
+596,700
+448% +$27.9M 0.06% 140
2025
Q2 		$6.17M Sell
133,300
-267,000
-67% -$13.1M 0.02% 352
2025
Q1 		$24.4M Sell
400,300
-224,100
-36% -$13.1M 0.06% 144
2024
Q4 		$35.3M Buy
624,400
+124,400
+25% +$6.95M 0.09% 138
2024
Q3 		$25.9M Buy
500,000
+5,700
+1% +$267K 0.08% 151
2024
Q2 		$20.5M Buy
494,300
+334,800
+210% +$15M 0.06% 184
2024
Q1 		$8.65M Sell
159,500
-222,600
-58% -$11.3M 0.03% 306
2023
Q4 		$19.6M Buy
382,100
+125,100
+49% +$6.57M 0.06% 212
2023
Q3 		$14.9M Buy
257,000
+42,200
+20% +$2.59M 0.07% 204
2023
Q2 		$13.7M Buy
214,800
+19,700
+10% +$1.32M 0.07% 202
2023
Q1 		$13.5M Sell
195,100
-73,800
-27% -$5.21M 0.07% 202
2022
Q4 		$19.3M Buy
268,900
+79,000
+42% +$5.96M 0.14% 111
2022
Q3 		$13.5M Sell
189,900
-74,200
-28% -$5.38M 0.08% 176
2022
Q2 		$20.3M Sell
264,100
-706,900
-73% -$53.8M 0.1% 122
2022
Q1 		$70.9M Sell
971,000
-673,000
-41% -$45.2M 0.19% 65
2021
Q4 		$103M Buy
1,644,000
+394,200
+32% +$23.1M 0.17% 106
2021
Q3 		$74M Sell
1,249,800
-275,600
-18% -$18.1M 0.15% 123
2021
Q2 		$102M Buy
1,525,400
+549,300
+56% +$35.8M 0.23% 92
2021
Q1 		$61.6M Buy
976,100
+133,600
+16% +$8.31M 0.18% 109
2020
Q4 		$52.3M Buy
842,500
+112,200
+15% +$6.9M 0.18% 101
2020
Q3 		$44M Buy
730,300
+127,200
+21% +$7.66M 0.23% 80
2020
Q2 		$35.5M Buy
603,100
+459,800
+321% +$27.5M 0.23% 73
2020
Q1 		$7.99M Sell
143,300
-982,000
-87% -$60M 0.13% 169
2019
Q4 		$72.2M Buy
1,125,300
+606,500
+117% +$34.7M 0.39% 43
2019
Q3 		$26.3M Buy
518,800
+143,300
+38% +$6.73M 0.18% 118
2019
Q2 		$17M Buy
375,500
+33,700
+10% +$1.57M 0.12% 180
2019
Q1 		$16.3M Buy
341,800
+112,200
+49% +$5.59M 0.15% 149
2018
Q4 		$11.9M Buy
229,600
+76,300
+50% +$4.1M 0.15% 115
2018
Q3 		$9.52M Buy
153,300
+116,000
+311% +$6.88M 0.11% 153
2018
Q2 		$2.06M Buy
37,300
+32,000
+604% +$1.73M 0.03% 273
2018
Q1 		$335K Buy
+5,300
New +$341K 0.01% 283
2017
Q2 		– Sell
-27,400
Closed -$1.49M – 651
2017
Q1 		$1.49M Hold
27,400
– – 0.04% 349
2016
Q4 		$1.6M Buy
+27,400
New +$1.5M 0.05% 325

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capstone Investment Advisors's BMY Position: Q1 2026 in Review

Capstone Investment Advisors reduced its Bristol-Myers Squibb (BMY) stake by 33% in Q1 2026, selling an estimated $525K and leaving 18,442 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #828.

Capstone Investment Advisors first reported a position in BMY in Q1 2014 and has held it in 28 quarters since. The position peaked at $18.1M in Q4 2023. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Capstone Investment Advisors held 18,442 shares of Bristol-Myers Squibb worth $1.12M as of Q1 2026.
  • Capstone Investment Advisors sold 9,008 Bristol-Myers Squibb shares in Q1 2026, an estimated $525K.
  • Bristol-Myers Squibb made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q1 2026, its #828 holding.
  • Capstone Investment Advisors first reported a position in Bristol-Myers Squibb in Q1 2014 and has held it in 28 quarters since.
  • Capstone Investment Advisors's Bristol-Myers Squibb position peaked at $18.1M in Q4 2023.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.